BCK Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

BCK Capital Management’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-34,394	Closed	-$604K	–	151
2021 Q3	$604K	Buy	+34,394	New	+$402K	0.36%	76

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

BCK Capital Management's TRIL Position: Q4 2021 in Review

BCK Capital Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 34,394 shares — an estimated $604K sold.

BCK Capital Management first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $604K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

BCK Capital Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
BCK Capital Management sold 34,394 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $604K.
BCK Capital Management first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
BCK Capital Management's Trillium Therapeutics Inc. position peaked at $604K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on BCK Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.